RYLPF (Koninklijke Philips NV) Tariff Resilience Score: 5/10 (As of Jun. 24, 2026)


RYLPF Koninklijke Philips NV RYLPF
73 GF Score
Price $26.19
GF Value $25.13
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Tariff Resilience Score?

Koninklijke Philips NV RYLPF 73 Tariff Resilience Score is 5 as of Jun. 24, 2026. GuruFocus rates RYLPF with a GF Score™ of 73/100 and a GF Value™ of $25.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 79% on this metric.

Koninklijke Philips NV has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Koninklijke Philips NV has Philips has a global supply chain with significant manufacturing in Asia and sales in the US and Europe. Past tariffs have impacted costs, but the company has some pricing power and is shifting production to mitigate risks. Industry-specific exemptions in healthcare provide partial relief.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Koninklijke Philips NV might have Average Resilient.

Koninklijke Philips NV  (OTCPK:RYLPF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Koninklijke Philips NV Tariff Resilience Score Related Terms

RYLPF vs ABT, SYK, MDT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Koninklijke Philips NV's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Koninklijke Philips NV Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's Tariff Resilience Score falls into.


RYLPF
73GF Score
Koninklijke Philips NV RYLPF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Koninklijke Philips NV (RYLPF) has a Tariff Resilience Score of 5 as of Jun. 24, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Koninklijke Philips NV ranks #176 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 21%.
Is Koninklijke Philips NV's Tariff Resilience Score too high?
Koninklijke Philips NV's current Tariff Resilience Score is 5. Based on the distribution chart, Koninklijke Philips NV ranks #176 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Koninklijke Philips NV has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Tariff Resilience Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #176 out of 838 companies for Tariff Resilience Score. This places Koninklijke Philips NV in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Koninklijke Philips NV's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.13, compared to a current price of $26.19 — trading 4.2% above its estimated fair value. The current Tariff Resilience Score is 5. Koninklijke Philips NV's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Tariff Resilience Score is 5 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued. The current stock price of $26.19 is trading 4.2% above its estimated GF Value™ of $25.13. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for RYLPF:

  • Tariff Resilience Score: 5
  • GF Value™: $25.13 vs. price of $26.19 (4.2% above fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
73GF Score

Get the complete analysis for RYLPF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.19
Price
$25.13
GF Value